Prepared by Dr. Michael Brown, CFA, Director of US Markets | Reviewed by Sofia Chen, Lead Editor | Report ID: IGEMINI-999B5D93-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns is seeking alpha reliable a Cautiously Constructive outlook for the next quarter. Key drivers include a P/E of 15.61x, 33.4% revenue expansion, and an RSI of 36 suggesting a neutral-bullish phase. We define critical support at $13995 and resistance at $17105.
Rating: Buy | Target Price: $20992.5 | Next Earnings: Jul 06
Download Full PDF Report
Price action carved a Inverse Head and Shoulders, confirmed by a 0.73x volume spike on May 05, 2026. The resistance at $13995 was tested.
RSI at 36 indicates a neutral-bullish state. Historical backtests suggest a +7.8% move within 10 sessions.
Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.
Relative to Healthcare peers, is seeking alpha reliable sits at the 60th percentile in valuation, offering a potential value opportunity.
With a market cap of $24.66B, is seeking alpha reliable operates in Healthcare. P/E of 15.61x is backed by 33.4% growth.
Options skew is toward call at the 16172 strike, positioning for a directional move.
Short float at 15.3% is below the sector average, reducing squeeze risk. Institutional ownership is 75%.
Dark pool prints show a 14%% surge in block trades, indicating institutional accumulation before Jul 06 earnings.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $15550 | $14772.5 |
| Market Cap | $24.66B | $27.13B |
| P/E Ratio | 15.61x | 13.3x |
| EPS (TTM) | $996.16 | $896.54 |
| Dividend Yield | 3.88% | 2.7% |
| Revenue Growth | 33.4% | 20% |
| Target Price | $20992.5 | - |
| Beta | 1.66 | 1.00 |